• 2 months 3 weeks ago Help us improve our website: http://t.co/vY9vRzmYRH! Please take our visitor survey: http://t.co/8gY0wRZtGx. Thank you...
  • 2 months 3 weeks ago 1st European Research Forum on Healthy Ageing: 03 Sept in Bxl. Policy makers, scientists, industrials: save the date! http://t.co/6TXrBI5rdt
  • 3 months 4 days ago Gender inequalities in health: a matter of policies according to @sophieproject http://t.co/TzwZzXko3g
  • 4 months 1 day ago 1/3 of cancer patients killed by 'fat-burning' process termed cachexia, @CNIO_Cancer researchers say http://t.co/GjfipsdG2R
  • 4 months 4 weeks ago New EU research project @pneumonp aims to tackle antibiotic resistance via inhalable nano therapeutics #nanomedicine http://t.co/VQN9WHojG2
  • 5 months 2 weeks ago Urban renewal improves the health of neighbours in Barcelona according to EU-funded project @sophieproject http://t.co/F0mKCdPBZ5
  • 5 months 2 weeks ago Check this article on #CommHERE: how to spread the word about research and reach out beyond the scientific community http://t.co/VDcKVDEfcc
  • 6 months 2 weeks ago Scientists @CNIO_Cancer among the 40 most important global researchers http://t.co/Rc0hIsq6dN
  • 6 months 3 weeks ago 2nd workshop @CIBER_ISCIII to strengthen the EU‐LAC Health Research Cooperation http://t.co/93qLQObcQj
  • 8 months 2 weeks ago The European Symposium in Drug Synthesis @unisiena will take place on May 18-23. You can register until April 15!! http://t.co/V8kxQIev9S

ASSURE

portrait of Prof. Nico Karssemeijer

Prof. Nico Karssemeijer

Scientific Coordinator of ASSURE, based at Radboud University Nijmegen Medical Centre, the Netherlands

Research field

Breast Cancer Screening

If you like this
If you want to know more
Research Profile

Who?

"I am fascinated by computer vision because it is so hard to teach a computer to see things the way humans do", says Nico Karssemeijer, Professor of Computer-Aided Diagnosis at Radboud University Nijmegen Medical Centre. With his team, he creates systems that help radiologists to detect early stages of disease in medical images.

Why?

About 1 in 8 women develop breast cancer during their lives. The number of cancers escaping detection with mammography is substantial. Personalised screening will increase the likelihood of early cancer detection, resulting in fewer deaths and an increased quality of life because less radical treatment is required.

What?

The purpose of breast screening is the early detection of breast cancer. Mammography, the standard method of breast cancer screening, misses many cancers, especially in dense-breasted women. The aim of ASSURE is to develop methods to personalise breast screening, based on breast density, age, gene mutations and family history.

How?

Four small and medium-sized enterprises have joined forces with leading research institutions and national screening experts in the ASSURE consortium. Together, they will develop the required tools for personalised breast cancer screening. New screening methods using MRI and automated breast ultrasound imaging will be developed.

Towards personalised breast cancer screening

In the Picture
In the Picture
Image credits

Background image: ASSURE

Portrait of the project coordinator: ASSURE

Timeline (in chronological order): 1913: Albaraa Mehdar on Flickr Creative Commons; 1963: Kaysha on Flickr Creative Commons; 1970s: ASSURE project website; late 1980s: Tips Times on Flickr Creative Commons; 1994: Josh*m on Flickr Creative Commons; 2008: Tips Times on Flickr Creative Commons